Stocktoria
Xeris Biopharma Holdings, Inc. XERS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-06-21
Xeris Biopharma Holdings, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 7,804,758 | $61.8M | 4.52% |
| BlackRock Finance, Inc. | 10,332,078 | $23.2M | 5.98% |
| TWO SIGMA INVESTMENTS, LP | 1,885,503 | $14.9M | 1.09% |
| AQR CAPITAL MANAGEMENT LLC | 1,540,985 | $12.2M | 0.89% |
| CITADEL ADVISORS LLC | 772,564 | $6.1M | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 131,664 | $1.0M | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 67,337 | $533,308 | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.